LINC02559

Across TCGA pan-cancer cohorts, LINC02559 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02559’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02559 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02559 is over-expressed in tumor.

BRCA, KICH, and KIRP are the cancer types where LINC02559 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02559 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.101	.030	4	view →
KICH	All	All	+0.478	<.001	2	view →
KIRP	All	All	+0.099	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC02559–BRCA

Open the BRCA breakdown →